SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1776[A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis andtuck-8/28/2007
1775>>MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytotuck-8/28/2007
1774The infatuation continues. Merrill: Aloxi rebound underway NDC data for Aloxi itom pope-8/27/2007
1773Mogn seems to be Ende's current favorite, or at least high on the list: Alotom pope-8/23/2007
1772ThinkEquity via Yahoo! MB regarding Vidaza results and outcome of Dacogen trial:tuck-8/9/2007
1771Clinical, Pharmacokinetic, and Pharmacodynamic Results of a Phase I Study of DecIcebrg-8/8/2007
1770Here are ML's notes on the PHRM results and how it'll affect SUPG/MOGN. Paul Lee-8/2/2007
1769MOGN beats handily, achieving Baird's target already after hours: >>Mtuck-7/18/2007
1768Well! biz.yahoo.comSteve Lokness-7/18/2007
1767MGI Pahrma "neutral," target price raised Monday, July 16, 2007 2:58:Icebrg-7/17/2007
1766SuperGen may or may not be a super investment URL: suburbanchicagonews.com JulIcebrg-7/12/2007
1765MGI PHARMA and HELSINN Announce Aloxi sNDA for PONV Accepted for Review By U.S. sim1-7/9/2007
1764MGI Pharma [Source: Bear Stearns] Reimbursement Rate for Zofran Declines as ExpIcebrg-6/22/2007
1763Practice Efficiency and Economics: The Case for Rapid Recovery Sedation Agents fIcebrg-6/21/2007
1762ML: MGI Pharma (MOGN, US$23.05, C-1-9) Reiterate Buy; Raising PT to $28 from $2tom pope-6/18/2007
1761MGI Pharma "buy," estimates raised Wednesday, June 06, 2007 6:59:31 AIcebrg-6/7/2007
1760>>MGI PHARMA Summarizes Data Presented at the 2007 American Society of Clituck-6/4/2007
17592007 Milestones [as reported at the Bank of America Healthcare Conference - slidIcebrg-6/1/2007
1758>>Aquavan(R) (Fospropofol Disodium) Injection Data Presented at Digestive tuck-5/23/2007
1757MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application sim1-5/7/2007
1756Not to my knowledge.Ward Knutson-4/27/2007
1755Ward, do you know if MOGN has any interest in the Chinese rights to Aloxi? Simctuck-4/26/2007
1754Here's Aloxi guidance (from Merrill, not the company) Aloxi beats, Dacogen tom pope-4/19/2007
1753MOGN beats, but still no Aloxi guidance (expected). Stock is off a bit after hotuck-4/18/2007
1752MGI Pharma "buy," target price raised - update Wednesday, March 21, 2Icebrg-3/22/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News